Morgan Stanley’s Abiomed Inc ABMD Stock Holding History

Morgan Stanley’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-250,016	Closed	-$61.4M	–	8040
2022 Q3	$61.4M	Sell	250,016 -24,751	-9%	-$6.68M	0.01%	1169
2022 Q2	$68M	Buy	274,767 +165,956	+153%	+$44.8M	0.01%	1170
2022 Q1	$36M	Buy	108,811 +9,575	+10%	+$2.95M	﹤0.01%	1542
2021 Q4	$35.6M	Buy	99,236 +1,210	+1%	+$409K	﹤0.01%	1611
2021 Q3	$31.9M	Sell	98,026 -21,421	-18%	-$7.26M	﹤0.01%	1648
2021 Q2	$37.3M	Buy	119,447 +25,558	+27%	+$7.84M	﹤0.01%	1549
2021 Q1	$29.9M	Sell	93,889 -48,216	-34%	-$15.4M	﹤0.01%	1559
2020 Q4	$46.1M	Buy	142,105 +33,935	+31%	+$9.39M	0.01%	1159
2020 Q3	$30M	Buy	108,170 +24,528	+29%	+$7.07M	0.01%	1195
2020 Q2	$20.2M	Sell	83,642 -8,790	-10%	-$1.76M	﹤0.01%	1395
2020 Q1	$13.4M	Sell	92,432 -146,127	-61%	-$24.3M	﹤0.01%	1561
2019 Q4	$40.7M	Buy	238,559 +37,346	+19%	+$6.92M	0.01%	1082
2019 Q3	$35.8M	Buy	201,213 +95,938	+91%	+$20.7M	0.01%	1068
2019 Q2	$27.4M	Sell	105,275 -42,481	-29%	-$11.3M	0.01%	1253
2019 Q1	$42.2M	Sell	147,756 -7,429	-5%	-$2.47M	0.01%	936
2018 Q4	$50.4M	Sell	155,185 -53,909	-26%	-$18.7M	0.02%	812
2018 Q3	$94M	Sell	209,094 -8,104	-4%	-$3.19M	0.02%	627
2018 Q2	$88.8M	Buy	217,198 +11,400	+6%	+$4.13M	0.02%	631
2018 Q1	$59.9M	Sell	205,798 -104,975	-34%	-$26.6M	0.02%	819
2017 Q4	$58.2M	Buy	310,773 +124,254	+67%	+$23.2M	0.02%	854
2017 Q3	$31.4M	Buy	186,519 +12,452	+7%	+$1.88M	0.01%	1218
2017 Q2	$24.9M	Buy	174,067 +24,035	+16%	+$3.23M	0.01%	1345
2017 Q1	$18.8M	Sell	150,032 -12,086	-7%	-$1.4M	0.01%	1632
2016 Q4	$18.3M	Sell	162,118 -134,581	-45%	-$15.6M	0.01%	1631
2016 Q3	$38.1M	Buy	296,699 +11,168	+4%	+$1.34M	0.01%	1012
2016 Q2	$31.2M	Buy	285,531 +133,007	+87%	+$13.2M	0.01%	1091
2016 Q1	$14.5M	Sell	152,524 -49,960	-25%	-$4.22M	0.01%	1577
2015 Q4	$18.3M	Sell	202,484 -108,444	-35%	-$9.2M	0.01%	1472
2015 Q3	$28.8M	Sell	310,928 -111,448	-26%	-$9.82M	0.01%	1122
2015 Q2	$27.8M	Buy	422,376 +111,384	+36%	+$7.4M	0.01%	1232
2015 Q1	$22.3M	Sell	310,992 -45,867	-13%	-$2.49M	0.01%	1374
2014 Q4	$13.6M	Buy	356,859 +133,735	+60%	+$4.22M	0.01%	1784
2014 Q3	$5.54M	Sell	223,124 -140,617	-39%	-$3.56M	﹤0.01%	2555
2014 Q2	$9.14M	Sell	363,741 -82,693	-19%	-$1.92M	﹤0.01%	2111
2014 Q1	$11.6M	Buy	446,434 +374,625	+522%	+$10.4M	﹤0.01%	1831
2013 Q4	$1.92M	Sell	71,809 -69,075	-49%	-$1.71M	﹤0.01%	3402
2013 Q3	$2.69M	Sell	140,884 -17,041	-11%	-$390K	﹤0.01%	2988
2013 Q2	$3.4M	Buy	+157,925	New	+$3.17M	﹤0.01%	2690

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Morgan Stanley's ABMD Position: Q4 2022 in Review

Morgan Stanley sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 250,016 shares — an estimated $61.4M sold.

Morgan Stanley first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $94M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Morgan Stanley reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Morgan Stanley sold 250,016 Abiomed Inc shares in Q4 2022, an estimated $61.4M.
Morgan Stanley first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
Morgan Stanley's Abiomed Inc position peaked at $94M in Q3 2018.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.